Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Lawyers for Johnson & Johnson’s Ovarian Cancer Victims React to SCOTUS Decision in Purdue

Beasley Allen: ‘We believe this decision should spell doom for J&J’s third bankruptcy plan’

The U.S. Supreme Court has denied a $7 billion Purdue Pharmaceuticals bankruptcy plan which would have given the Sackler family, which founded the company, immunity from additional liability for their irresponsible actions in promoting the deadly use of opioids to the public and physicians.

The Sackler family had agreed to provide up to $6 billion in funding in exchange for immunity from further legal action while protecting billions in other assets. But the court ruled 5-4 that bankruptcy law does not permit that kind of protection.

The decision has significant implications for ongoing efforts by Johnson & Johnson (NYSE: JNJ) to seek bankruptcy protection in an effort to resolve tens of thousands of ovarian cancer claims tied to the use of the company’s talc-based products, including the Johnson’s Baby Powder and Shower to Shower brands.

In response, the following is a statement from Leigh O’Dell of the Beasley Allen Law Firm and Co-Chair of the Plaintiffs’ Steering Committee in the Talc/Ovarian Cancer MDL in New Jersey Federal Court.

“We believe this decision should spell doom for J&J’s third bankruptcy plan. Today’s ruling affirms that financially solvent entities, or individuals, cannot use the bankruptcy courts as a shield to escape liability for marketing and manufacturing dangerous products.

“The parallels of this case with J&J’s continued and unsuccessful attempts to use the bankruptcy laws to mirror the fraud perpetrated by the Sackler family cannot be denied. Even with an overwhelming majority of creditors approving the Sacklers’ indemnification scheme, the principles of fundamental fairness -- that it is the debtor who may receive the benefits of bankruptcy not other wrongdoers (such as the Sacklers or J&J) -- have been upheld.

“We hope that this decision provides clarity to the controversy that resulted in rampant forum shopping by companies and inconsistent administration of the code by the courts. We also hope that this decision will derail any attempt by J&J to return the talc litigation to the bankruptcy courts, and we can continue to move forward with trials that support the constitutional rights of our clients and resolutions that consider the true financial and emotional toll suffered by thousands of J&J’s victims.

“J&J’s response to today’s Supreme Court ruling in the Sackler case reveals a half-trillion-dollar company still desperate to use bankruptcy as a shield to protect itself from the tens of thousands of women who have cancer only because they used Johnson’s Baby Powder or Shower to Shower. It won’t work.

“Despite mountains of evidence to the contrary, J&J continues to mislead juries and members of the public by claiming talc-based baby powder doesn’t contain asbestos. Yet, at the same time, J&J seeks the shelter of a bankruptcy escape hatch that Congress designed exclusively for asbestos-containing products. They can’t have it both ways. It’s time for J&J to abandon its hysterical, bullying, and untruthful rhetoric and act as a responsible corporation.”

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.